R079 - CAS 2115659-62-4

R079 (compound 17), a selective and orally active Nrf2 activator, enhances Nrf2 translocation activity (EC 50 = 32.41 μM) and can neutralize excess levels of reactive oxygen species by activating Nrf2. Additionally, R079 possesses anti-inflammatory properties and has applications in multiple sclerosis research [1].

Nrf2

Immunology/Inflammation

2115659-62-4

C11H11N3O3S

265.29

C(=C/S(=O)(=O)C1=CC=CC=C1)\N2C(=O)N(C)C=N2

-20°C

Ice Packs

Small Compound